- Home
- THW vs MRVI Comparison
THW vs MRVI Comparison
Compare THW & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THW
- MRVI
- Stock Information
- Founded
- THW 2015
- MRVI 2014
- Country
- THW United States
- MRVI United States
- Employees
- THW N/A
- MRVI N/A
- Industry
- THW Finance Companies
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- THW Finance
- MRVI Health Care
- Exchange
- THW Nasdaq
- MRVI Nasdaq
- Market Cap
- THW 438.1M
- MRVI 371.8M
- IPO Year
- THW N/A
- MRVI 2020
- Fundamental
- Price
- THW $11.57
- MRVI $2.45
- Analyst Decision
- THW
- MRVI Hold
- Analyst Count
- THW 0
- MRVI 10
- Target Price
- THW N/A
- MRVI $5.84
- AVG Volume (30 Days)
- THW 149.9K
- MRVI 1.5M
- Earning Date
- THW 01-01-0001
- MRVI 08-11-2025
- Dividend Yield
- THW 10.76%
- MRVI N/A
- EPS Growth
- THW N/A
- MRVI N/A
- EPS
- THW N/A
- MRVI N/A
- Revenue
- THW N/A
- MRVI $219,830,000.00
- Revenue This Year
- THW N/A
- MRVI N/A
- Revenue Next Year
- THW N/A
- MRVI $10.70
- P/E Ratio
- THW N/A
- MRVI N/A
- Revenue Growth
- THW N/A
- MRVI N/A
- 52 Week Low
- THW $9.76
- MRVI $1.67
- 52 Week High
- THW $14.89
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- THW 69.23
- MRVI 50.12
- Support Level
- THW $10.75
- MRVI $2.35
- Resistance Level
- THW $11.65
- MRVI $2.71
- Average True Range (ATR)
- THW 0.16
- MRVI 0.17
- MACD
- THW 0.06
- MRVI 0.01
- Stochastic Oscillator
- THW 92.38
- MRVI 57.50
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.